Navigation Links
Cold Spring Harbor Laboratory Appoints Teri F. Willey to Accelerate Commercialization Efforts
Date:9/10/2013

Cold Spring Harbor, NY (PRWEB) September 10, 2013

Cold Spring Harbor Laboratory (CSHL) today announced that Teri F. Willey has been appointed Vice President of Business Development and Technology Transfer. In this newly created position, Ms. Willey will direct the Laboratory’s commercialization and technology transfer activities, including patenting, licensing, company start-ups, and corporate partnerships and collaborations.

Ms Willey joins CSHL from Mount Sinai Medical Center, where she successfully led the center’s technology transfer and business development efforts. John Maroney, who previously had responsibility for technology transfer activities, will continue in his role as General Counsel.

Ranked #1 in the world for research impact in the fields of molecular biology and genetics, CSHL has a rich history of biomedical discovery and technology advancement and has sparked more than 20 start-up biotech companies -- including one of Long Island’s biggest pharmaceutical success stories, cancer drug developer OSI Pharmaceuticals, which was recently acquired by Astellas.

“CSHL’s transformative discoveries over many years in such areas as cancer, autism and other neuropsychiatric disorders, genome analysis, plant biology, and biofuels have significant commercial applications that will improve diagnostic and therapeutic approaches in the clinic as well as in agriculture and energy production,” said CSHL President Bruce Stillman. “The appointment of Teri Willey to this new position will ensure that our research advances are applied to society’s biggest challenges in healthcare, the environment, and world hunger and will enable us to maximize the economic potential of the biomedical research cluster on Long Island. Ms. Willey has an outstanding reputation and track record, and we are extremely pleased to welcome her to CSHL.”

“Underlying the strength of Long Island’s biomedical research cluster are leaders like John Maroney, who has been an integral part of CSHL as Vice President of Technology Transfer and General Counsel for 20 years,” Dr. Stillman continued. “With successes that include the founding of the Broad Hollow Bioscience Park in 2000, John has helped lay the foundation for Long Island to leverage the academic and clinical assets of its leading institutions, including CSHL, Stony Brook University, Brookhaven National Laboratory, Hofstra University, and the North Shore-LIJ Health System. We are extremely grateful for his many contributions and look forward to his continued service to CSHL as General Counsel.”

Ms. Willey has had a distinguished career in technology transfer and venture capital. Most recently, she served as Vice President of Technology & Business Development at Mount Sinai Medical Center in Manhattan. As the head of commercialization at Mount Sinai, she is credited with reorganizing technology transfer to support the medical center’s vibrant innovation agenda through partnerships with industry, investors and funders.

Prior to joining Mount Sinai, Ms. Willey was founding Chief Executive and Executive Director, Cambridge Enterprise Ltd, The University of Cambridge, UK, and was a co-founder and Managing Partner of ARCH Development Partners, a seed venture fund and spin out from the University of Chicago and Argonne National Laboratory technologies. Earlier in her career, she served in technology transfer and business development at Purdue Research Foundation, Indiana Corporation for Science & Technology, and Northwestern University. She has served as an advisor to Congress and is a past President of the Association of University Technology Managers.

About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL is ranked number one in the world by Thomson Reuters for the impact of its research in molecular biology and genetics. The Laboratory has been home to eight Nobel Prize winners. Today, CSHL's multidisciplinary scientific community is more than 600 researchers and technicians strong and its Meetings & Courses program hosts more than 12,000 scientists from around the world each year to its Long Island campus and its China center. Tens of thousands more benefit from the research, reviews, and ideas published in journals and books distributed internationally by CSHL Press. The Laboratory's education arm also includes a graduate school and programs for middle and high school students and teachers. CSHL is a private, not-for-profit institution on the north shore of Long Island. For more information, visit http://www.cshl.edu.

Contact

Cold Spring Harbor Laboratory
Dagnia Zeidlickis
516-367-8455
zeidlick(at)cshl(dot)edu

Read the full story at http://www.prweb.com/releases/2013/9/prweb11104799.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Veracyte Appoints Mark Spring as Chief Financial Officer
2. In new mass-production technique, robotic insects spring to life
3. Thomas Elsaesser and Horst Weller receive the Julius Springer Prize for Applied Physics 2012
4. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
5. Springer to publish new open access journal with the Korean Society for Micro and Nano Systems
6. Nerium Hosts Spring Bash 2013 in Various Locations
7. Topricin Selected for Bruce Springsteen MusiCares’ Tribute Gala
8. How to Do Spring Cleaning the Healthy Way: DistinctBright Explores the Overlooked Dangers of Household Cleaning Products and offers Natural Cleaning Solutions
9. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
10. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
11. 2013 Bio Convention Provides Springboard For Malaysian Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):